Sea Crest Wealth Management, LLC Dexcom Inc Transaction History

Sea Crest Wealth Management, LLC

$916 Million
Q4 2024

A detailed history of Sea Crest Wealth Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 4,447 shares of DXCM stock, worth $382,397. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,447

Previous 4,427 0.45%

Holding current value

$382,397

Previous $296,000 16.55%

% of portfolio

0.04%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	BUY	$65.68 - $81.01 $1,313 - $1,620	20 Added 0.45%	4,447 $345,000
Q3 2024 Oct 16, 2024	BUY	$64.0 - $116.06 $384 - $696	6 Added 0.14%	4,427 $296,000
Q2 2024 Jul 19, 2024	BUY	$110.31 - $140.45 $16,767 - $21,348	152 Added 3.56%	4,421 $501,000
Q1 2024 Apr 18, 2024	SELL	$114.22 - $140.1 $913 - $1,120	-8 Reduced 0.19%	4,269 $592,000
Q4 2023 Jan 18, 2024	SELL	$75.49 - $124.16 $226,620 - $372,728	-3,002 Reduced 41.24%	4,277 $530,000
Q3 2023 Oct 12, 2023	BUY	$86.06 - $137.93 $9,122 - $14,620	106 Added 1.48%	7,279 $679,000
Q2 2023 Jul 14, 2023	SELL	$112.47 - $130.98 $1,687 - $1,964	-15 Reduced 0.21%	7,173 $921,000
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $832 - $983	8 Added 0.11%	7,188 $835,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $15,041 - $21,712	177 Added 2.53%	7,180 $813,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $203,854 - $251,460	2,670 Added 61.62%	7,003 $564,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $225,590 - $440,929	3,318 Added 326.9%	4,333 $323,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $3,857 - $5,338	41 Added 4.21%	1,015 $519,000
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $13,766 - $17,258	-106 Reduced 9.81%	974 $523,000
Q3 2021 Nov 16, 2021	SELL	$106.71 - $143.18 $426 - $572	-4 Reduced 0.37%	1,080 $591,000
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $4,292 - $5,720	53 Added 5.14%	1,084 $463,000
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $1,950 - $2,409	-23 Reduced 2.18%	1,031 $371,000
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $3,276 - $4,389	42 Added 4.15%	1,054 $390,000
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $191 - $225	-2 Reduced 0.2%	1,012 $417,000
Q2 2020 Jul 27, 2020	SELL	$62.68 - $105.34 $6,017 - $10,112	-96 Reduced 8.65%	1,014 $411,000
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $12,234 - $19,361	-256 Reduced 18.74%	1,110 $299,000
Q4 2019 Jan 22, 2020	SELL	$36.62 - $57.29 $1,721 - $2,692	-47 Reduced 3.33%	1,366 $299,000
Q3 2019 Oct 15, 2019	BUY	$35.53 - $43.8 $2,593 - $3,197	73 Added 5.45%	1,413 $211,000
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $1,349 - $1,868	50 Added 3.88%	1,340 $161,000
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $583 - $918	25 Added 1.98%	1,290 $185,000
Q4 2017 Feb 02, 2018	BUY	$11.12 - $15.38 $14,066 - $19,455	1,265	1,265 $73,000

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.

Account

Sea Crest Wealth Management, LLC Dexcom Inc Transaction History